MG-2209
N/A
Report date: 2025/04/30 16:00:42
Base Information
Drug NameMG-2209
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Maijin Biomedical Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Maijin Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A